Kloth, Jacqueline S L <br/><br/>
Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Mar 2016 
 - 101-106 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2015.12.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Renal Cell--blood<br/>Disease-Free Survival<br/>Erythrocyte Indices<br/>Erythrocytes--drug effects<br/>Female<br/>Hemoglobins--metabolism<br/>Humans<br/>Indoles--adverse effects<br/>Kidney Neoplasms--blood<br/>Male<br/>Molecular Targeted Therapy<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Protein Kinase Inhibitors--adverse effects<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--adverse effects<br/>Retrospective Studies<br/>Risk Factors<br/>Sunitinib<br/>Time Factors<br/>Treatment Outcome